Tag:
oral formulation
Latest Headlines
Latest Headlines
Unigene regains treatment rights as GSK backs out
Unigene Laboratories ( $UGNE ) says it has regained the global rights to an oral formulation of a parathyroid hormone analog to treat osteoporosis in postmenopausal women from GlaxoSmithKline ( $GSK ).
